HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium Hydroxide → 10,11-Dihydrodibenzo(b,f)(1,4)oxazepine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 8-Chloro-10,11-dihydrodibenzo[b,f][1,4]oxazepine | HCID 15229227 | — |
| Reactant | HCID 178418361 | HCID 178418361 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | 10,11-Dihydrodibenzo(b,f)(1,4)oxazepine | HCID 648933 | 68.1% |
Reaction Steps
A solution of 2.0 g of 8-chloro-10,11-dihydrodibenz [b,f][1,4]oxazepine, 0.77 g of sodium hydroxide, and 5% palladium on carbon in 50 mL of ethanol (3A) was shaken at 60 psi hydrogen in a Parr hydrogenator at room temperature for 3.67 hours. The catalyst was filtered from the reaction and the solution was evaporated under vacuum. The residue was taken up in chloroform, washed with water and brine, dried over magnesium sulfate, and evaporated under vacuum to yield 1.16 g (68.1%) of 10,11-dihydrodibenz[b,f][1,4]oxazepine as a tan solid. Mp: 74°-76° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05304644 |
| Source dataset | uspto-grants-1994_04 |
| ORD ID | ord-c84fd76960a04ab6a3617283e7b44501 |
| Source note | uspto-grants-1994_04 |